Factors Associated With Nocturnal Hypoglycemia After Exercise in the Type 1 Diabetes and Exercise Initiative (T1DEXI) Study.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 42247270.
- Also identified by DOI 10.2337/dc26-0381.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To identify modifiable factors associated with postexercise nocturnal hypoglycemia in the Type 1 Diabetes and Exercise Initiative (T1DEXI) study. In this real-world prospective cohort study, overnight continuous glucose monitoring data following exercise days versus sedentary days were assessed in adults with type 1 diabetes. Nocturnal hypoglycemia was defined as a continuous glucose monitoring level of 54-69 mg/dL (level 1) or <54 mg/dL (level 2) for ≥15 min between midnight and 6:00 a.m. Among 496 adults across 12,340 nights, exercise days were associated with more frequent level 1 nocturnal hypoglycemia relative to sedentary days (15.6% vs. 13.1%, P = 0.001). Factors associated with reduced risk included lower preexercise time below range, higher preexercise and bedtime glucose, absence of hypoglycemia during or within 4 h after exercise, and hybrid closed-loop delivery. Time below range ≥4% in the 24 h preceding exercise was associated with substantially higher nocturnal hypoglycemia risk relative to <4% for level 1 (22.9% vs. 11.7%) and level 2 (10.2% vs. 3.3%) (both P < 0.001). Hybrid closed-loop users experienced approximately half the rate of nocturnal hypoglycemia compared with participants using standard pumps or multiple daily injections (level 1: 9.7% vs. 20.3% vs. 17.3%, respectively; level 2: 3.2% vs. 7.2% vs. 5.8%, respectively) (both P < 0.001). In the T1DEXI study, exercise was associated with increased nocturnal hypoglycemia risk in adults with type 1 diabetes. Targeting modifiable factors may reduce risk and address a critical barrier to safe physical activity in type 1 diabetes.